About Pacific Coast Biologics
Founded in 2000, Pacific Coast Biologics specialises in the development and manufacture of animal-free recombinant proteins for life science research, cell culture and bioprocess applications. The company focuses on producing high-purity cytokines, growth factors and signalling molecules that enable researchers to investigate cellular function, differentiation, proliferation and immune responses using defined, animal component-free reagents. Its expertise supports workflows in stem cell research, regenerative medicine, immunology, oncology and biopharmaceutical development, where consistent and well-characterised protein reagents are required.
Pacific Coast Biologics’ portfolio includes recombinant growth factors, interleukins, interferons, colony-stimulating factors, neurotrophic factors, tumour necrosis factors, bone morphogenetic proteins and members of the TGF-β family. Manufactured to support research and cell culture applications, these proteins are used in studies of cellular signalling, tissue engineering, immune regulation and therapeutic development. The company’s animal-free production approach helps researchers reduce variability associated with serum-derived components while supporting more defined experimental conditions.
Europa Biosite’s subsidiaries distribute for Pacific Coast Biologics in Austria, Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.